nnc0109-0012
Showing 1 - 3 of 3
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntington Beach, California
- +139 more
Sep 3, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntsville, Alabama
- +163 more
Sep 3, 2018
Inflammation, Rheumatoid Arthritis Trial (NNC0109-0012, Adalimumab, )
Withdrawn
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- +2 more
- (no location specified)
Aug 13, 2014